Naser Jafari

887 total citations
25 papers, 670 citations indexed

About

Naser Jafari is a scholar working on Molecular Biology, Cancer Research and Immunology and Allergy. According to data from OpenAlex, Naser Jafari has authored 25 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 10 papers in Cancer Research and 4 papers in Immunology and Allergy. Recurrent topics in Naser Jafari's work include MicroRNA in disease regulation (5 papers), Extracellular vesicles in disease (4 papers) and Cell Adhesion Molecules Research (4 papers). Naser Jafari is often cited by papers focused on MicroRNA in disease regulation (5 papers), Extracellular vesicles in disease (4 papers) and Cell Adhesion Molecules Research (4 papers). Naser Jafari collaborates with scholars based in United States, Iran and France. Naser Jafari's co-authors include Gerald V. Denis, Hadi Peeridogaheh, Shahab Bohlooli, Jordan Shafran, B. Mark Evers, Heidi L. Weiss, Yekaterina Y. Zaytseva, Chi Wang, Piotr Rychahou and Seyed Jalal Zargar and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Naser Jafari

25 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naser Jafari United States 17 424 262 87 79 67 25 670
Gao Liu China 14 470 1.1× 388 1.5× 133 1.5× 156 2.0× 54 0.8× 35 833
Hae Jong Kim South Korea 15 318 0.8× 89 0.3× 123 1.4× 92 1.2× 49 0.7× 32 625
Xin Song China 16 662 1.6× 385 1.5× 211 2.4× 94 1.2× 54 0.8× 31 921
Jin Zou China 14 343 0.8× 151 0.6× 83 1.0× 51 0.6× 35 0.5× 21 552
Weiwen Chen China 16 505 1.2× 305 1.2× 83 1.0× 64 0.8× 38 0.6× 37 678
Ashik Jawahar Deen Finland 13 483 1.1× 148 0.6× 47 0.5× 80 1.0× 180 2.7× 15 640
Aihong Wang China 16 513 1.2× 338 1.3× 143 1.6× 100 1.3× 31 0.5× 40 740
Jia‐Ru Wu Taiwan 14 352 0.8× 118 0.5× 94 1.1× 63 0.8× 77 1.1× 22 578
Ying‐Erh Chou Taiwan 18 488 1.2× 233 0.9× 173 2.0× 62 0.8× 79 1.2× 45 733
Jingyu Zhang China 14 401 0.9× 205 0.8× 116 1.3× 46 0.6× 30 0.4× 41 611

Countries citing papers authored by Naser Jafari

Since Specialization
Citations

This map shows the geographic impact of Naser Jafari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naser Jafari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naser Jafari more than expected).

Fields of papers citing papers by Naser Jafari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naser Jafari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naser Jafari. The network helps show where Naser Jafari may publish in the future.

Co-authorship network of co-authors of Naser Jafari

This figure shows the co-authorship network connecting the top 25 collaborators of Naser Jafari. A scholar is included among the top collaborators of Naser Jafari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naser Jafari. Naser Jafari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jafari, Naser, et al.. (2022). Exosomes as novel biomarkers in metabolic disease and obesity-related cancers. Nature Reviews Endocrinology. 18(6). 327–328. 33 indexed citations
2.
Jafari, Naser, Andrew Chen, Yuhan Qiu, et al.. (2022). Novel plasma exosome biomarkers for prostate cancer progression in co-morbid metabolic disease. SHILAP Revista de lepidopterología. 6. 100073–100073. 6 indexed citations
3.
Rychahou, Piotr, Daheng He, Naser Jafari, et al.. (2020). Inhibition of Fatty Acid Synthase Upregulates Expression of CD36 to Sustain Proliferation of Colorectal Cancer Cells. Frontiers in Oncology. 10. 1185–1185. 76 indexed citations
4.
Shafran, Jordan, et al.. (2020). BRD4 regulates key transcription factors that drive epithelial–mesenchymal transition in castration-resistant prostate cancer. Prostate Cancer and Prostatic Diseases. 24(1). 268–277. 32 indexed citations
5.
Jafari, Naser, et al.. (2019). Abstract 4375: Overexpression of CD36 promotes colorectal cancer cell proliferation via upregulation of survivin. Cancer Research. 79(13_Supplement). 4375–4375. 2 indexed citations
6.
Andrieu, Guillaume P., et al.. (2019). BET protein targeting suppresses the PD-1/PD-L1 pathway in triple-negative breast cancer and elicits anti-tumor immune response. Cancer Letters. 465. 45–58. 44 indexed citations
7.
Jafari, Naser, Andrew J. Morris, Fredrick O. Onono, et al.. (2018). De Novo Fatty Acid Synthesis-Driven Sphingolipid Metabolism Promotes Metastatic Potential of Colorectal Cancer. Molecular Cancer Research. 17(1). 140–152. 58 indexed citations
8.
Li, Liqing, Xiang Li, Lei S. Qi, et al.. (2017). The role of talin2 in breast cancer tumorigenesis and metastasis. Oncotarget. 8(63). 106876–106887. 15 indexed citations
9.
Jafari, Naser, et al.. (2017). Potent anti-cancer effects of less polar Curcumin analogues on gastric adenocarcinoma and esophageal squamous cell carcinoma cells. Scientific Reports. 7(1). 2559–2559. 45 indexed citations
10.
Jafari, Naser, Seyed Jalal Zargar, Mohammad‐Reza Delnavazi, & Narguess Yassa. (2017). Cell Cycle Arrest and Apoptosis Induction of Phloroacetophenone Glycosides and Caffeoylquinic Acid Derivatives in Gastric Adenocarcinoma (AGS) Cells. Anti-Cancer Agents in Medicinal Chemistry. 18(4). 610–616. 20 indexed citations
11.
Jafari, Naser, Hyun-Ju Kim, Rackhyun Park, et al.. (2017). CRISPR-Cas9 Mediated NOX4 Knockout Inhibits Cell Proliferation and Invasion in HeLa Cells. PLoS ONE. 12(1). e0170327–e0170327. 24 indexed citations
12.
Aslani, Saeed, et al.. (2016). Epigenetic Modifications and Therapy in Multiple Sclerosis. NeuroMolecular Medicine. 19(1). 11–23. 52 indexed citations
13.
Qi, Lei, Naser Jafari, Xiang Li, et al.. (2016). Talin2-mediated traction force drives matrix degradation and cell invasion. Journal of Cell Science. 129(19). 3661–3674. 32 indexed citations
14.
Jafari, Naser, et al.. (2015). The Function of Ubiquitin Protein Ligase E3A and its Roles in Human Diseases. 1(1). 1 indexed citations
15.
Jafari, Naser, et al.. (2014). Overexpression of microRNA biogenesis machinery: Drosha, DGCR8 and Dicer in multiple sclerosis patients. Journal of Clinical Neuroscience. 22(1). 200–203. 17 indexed citations
16.
Jafari, Naser, et al.. (2014). Upregulation of microRNA Processing Enzymes Drosha and Dicer in Gestational Diabetes Mellitus. Gynecological Endocrinology. 31(2). 156–159. 29 indexed citations
17.
Jafari, Naser, et al.. (2013). Expression levels of microRNA machinery components Drosha, Dicer and DGCR8 in human (AGS, HepG2, and KEYSE-30) cancer cell lines.. PubMed. 6(4). 269–74. 19 indexed citations
18.
Bohlooli, Shahab, et al.. (2012). Cytotoxic Effect of Freeze-Dried Extract of Ecballium elaterium Fruit on Gastric Adenocarcinoma (AGS) and Esophageal Squamous Cell Carcinoma (KYSE30) Cell Lines. Journal of Gastrointestinal Cancer. 43(4). 579–583. 27 indexed citations
19.
Jafari, Naser, et al.. (2011). Cytotoxicity of Methylsulfonylmethane on Gastrointestinal (AGS, HepG2, and KEYSE-30) Cancer Cell Lines. Journal of Gastrointestinal Cancer. 43(3). 420–425. 20 indexed citations
20.
Ruddon, Raymond W., et al.. (1989). Biosynthesis and Deposition of a Noncovalent Laminin-Heparan Sulfate Proteoglycan Complex and Other Basal Lamina Components by a Human Malignant Cell Line. Journal of Biological Chemistry. 264(6). 3078–3088. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gao Liu Breakdown of academic impact, for papers by Hae Jong Kim Breakdown of academic impact, for papers by Xin Song Breakdown of academic impact, for papers by Jin Zou Breakdown of academic impact, for papers by Weiwen Chen Breakdown of academic impact, for papers by Ashik Jawahar Deen Breakdown of academic impact, for papers by Aihong Wang Breakdown of academic impact, for papers by Jia‐Ru Wu Breakdown of academic impact, for papers by Ying‐Erh Chou Breakdown of academic impact, for papers by Jingyu Zhang
Rankless by CCL
2026